297 related articles for article (PubMed ID: 29654229)
1. Somatic genome editing with the RCAS-TVA-CRISPR-Cas9 system for precision tumor modeling.
Oldrini B; Curiel-García Á; Marques C; Matia V; Uluçkan Ö; Graña-Castro O; Torres-Ruiz R; Rodriguez-Perales S; Huse JT; Squatrito M
Nat Commun; 2018 Apr; 9(1):1466. PubMed ID: 29654229
[TBL] [Abstract][Full Text] [Related]
2. Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target.
Cook PJ; Thomas R; Kannan R; de Leon ES; Drilon A; Rosenblum MK; Scaltriti M; Benezra R; Ventura A
Nat Commun; 2017 Jul; 8():15987. PubMed ID: 28695888
[TBL] [Abstract][Full Text] [Related]
3. A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination.
Ideno N; Yamaguchi H; Okumura T; Huang J; Brun MJ; Ho ML; Suh J; Gupta S; Maitra A; Ghosh B
Lab Invest; 2019 Jul; 99(8):1233-1244. PubMed ID: 30728464
[TBL] [Abstract][Full Text] [Related]
4. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
[TBL] [Abstract][Full Text] [Related]
5. Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines.
Wassef M; Luscan A; Battistella A; Le Corre S; Li H; Wallace MR; Vidaud M; Margueron R
Methods; 2017 May; 121-122():45-54. PubMed ID: 28499832
[TBL] [Abstract][Full Text] [Related]
6. P53 ICE CRIM mouse: a tool to generate mutant allelic series in somatic cells and germ lines for cancer studies.
Fan HH; Yu IS; Lin YH; Wang SY; Liaw YH; Chen PL; Yang TL; Lin SW; Chen YT
FASEB J; 2019 Apr; 33(4):5571-5584. PubMed ID: 30640520
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
Vermersch E; Jouve C; Hulot JS
Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
[TBL] [Abstract][Full Text] [Related]
8. Precision genome editing in the CRISPR era.
Salsman J; Dellaire G
Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
[TBL] [Abstract][Full Text] [Related]
9. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
Albadri S; Del Bene F; Revenu C
Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
[TBL] [Abstract][Full Text] [Related]
10. Exome sequencing in the knockin mice generated using the CRISPR/Cas system.
Nakajima K; Kazuno AA; Kelsoe J; Nakanishi M; Takumi T; Kato T
Sci Rep; 2016 Oct; 6():34703. PubMed ID: 27698470
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9 editing of the genome for cancer modeling.
Guernet A; Grumolato L
Methods; 2017 May; 121-122():130-137. PubMed ID: 28288827
[TBL] [Abstract][Full Text] [Related]
12. Highly Efficient Mouse Genome Editing by CRISPR Ribonucleoprotein Electroporation of Zygotes.
Chen S; Lee B; Lee AY; Modzelewski AJ; He L
J Biol Chem; 2016 Jul; 291(28):14457-67. PubMed ID: 27151215
[TBL] [Abstract][Full Text] [Related]
13. Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAs.
Rose JC; Popp NA; Richardson CD; Stephany JJ; Mathieu J; Wei CT; Corn JE; Maly DJ; Fowler DM
Nat Commun; 2020 Jun; 11(1):2697. PubMed ID: 32483117
[TBL] [Abstract][Full Text] [Related]
14. Analysing the outcome of CRISPR-aided genome editing in embryos: Screening, genotyping and quality control.
Mianné J; Codner GF; Caulder A; Fell R; Hutchison M; King R; Stewart ME; Wells S; Teboul L
Methods; 2017 May; 121-122():68-76. PubMed ID: 28363792
[TBL] [Abstract][Full Text] [Related]
15. Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field.
He ZY; Men K; Qin Z; Yang Y; Xu T; Wei YQ
Sci China Life Sci; 2017 May; 60(5):458-467. PubMed ID: 28527117
[TBL] [Abstract][Full Text] [Related]
16. Genome Editing Reveals Glioblastoma Addiction to MicroRNA-10b.
El Fatimy R; Subramanian S; Uhlmann EJ; Krichevsky AM
Mol Ther; 2017 Feb; 25(2):368-378. PubMed ID: 28153089
[TBL] [Abstract][Full Text] [Related]
17. Optimization of genome editing through CRISPR-Cas9 engineering.
Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
[TBL] [Abstract][Full Text] [Related]
18. Genome editing via delivery of Cas9 ribonucleoprotein.
DeWitt MA; Corn JE; Carroll D
Methods; 2017 May; 121-122():9-15. PubMed ID: 28410976
[TBL] [Abstract][Full Text] [Related]
19. Genome Editing with AAV-BR1-CRISPR in Postnatal Mouse Brain Endothelial Cells.
Song X; Cui Y; Wang Y; Zhang Y; He Q; Yu Z; Xu C; Ning H; Han Y; Cai Y; Cheng X; Wang J; Teng Y; Yang X; Wang J
Int J Biol Sci; 2022; 18(2):652-660. PubMed ID: 35002515
[TBL] [Abstract][Full Text] [Related]
20. Precision genome editing using CRISPR-Cas9 and linear repair templates in C. elegans.
Paix A; Folkmann A; Seydoux G
Methods; 2017 May; 121-122():86-93. PubMed ID: 28392263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]